10-Q
Quarterly Report
Actuate Therapeutics, Inc.
ACTU
NASDAQ
CIK: 1652935
File #: 001-42139
Balance Sheet
31 line items · 2 periods
XBRL
| Item | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 16,924,763 | 8,641,622 |
Other Non-Operating Current Assets | 519,237 | 566,278 |
Total current assets | 17,444,000 | 9,207,900 |
Other Non-Operating Non-Current Assets | 269,934 | 110,548 |
Total assets | 17,713,934 | 9,318,448 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 1,245,375 | 1,921,189 |
Other Non-Operating Current Liabilities | 4,259,048 | 5,921,908 |
Other Current Liabilities | 846,283 | 888,449 |
Other Non-Operating Current Liabilities | 21,956 | 70,957 |
U I C License Agreement | — | 70,957 |
Total current liabilities | 6,372,662 | 8,802,503 |
Long term liabilities: | ||
Accrued interest, less current portion | 0 | 6,768 |
U I C License Agreement | — | 6,768 |
License payable | 404,991 | 404,991 |
Total long-term liabilities | 404,991 | 411,759 |
Total liabilities | 6,777,653 | 9,214,262 |
Stockholders’ equity: | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 23 | 20 |
Total Stockholders' Equity | 160,990,006 | 132,484,015 |
Total Stockholders' Equity | (150,053,748) | (132,379,849) |
Total stockholders’ equity | 10,936,281 | 104,186 |
Common Stock | 23 | 20 |
Additional Paid-in Capital | 160,990,006 | 132,484,015 |
Retained Earnings | (150,053,748) | (132,379,849) |
Total liabilities and stockholders’ equity | 17,713,934 | 9,318,448 |